Lurbinectedin In SCLC
A new drug application (NDA) has been registered for expedited approval with the FDA for lurbinectedin in sufferers with small-cell lung cancer (SCLC) who have…
February 2020
PharmaMar and Jazz Pharmaceutical: U.S. License Agreement for Lurbinectedin
PharmaMar (MSE: PHM) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) state that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended “HSR,”…
The Herpes Zoster: In-Depth Research
Shingles (herpes zoster) is a viral illness most often linked with and diagnosed by the presence of a red, blistering disease that typically appears as…
The Submission Of A New Drug Application
Luye Pharma Group has published the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for LY03005, a different…
Gene Treatment: The Newest Ways To Implement
This is a crucial time in the field of gene treatment as the FDA (Food And Drug Administration) maintains its attempts to encourage innovators emerging…
Peanut Allergy: The FDA Treatment
Administrators with the FDA (Food And Drug Administration) have confirmed Aimmune Therapeutics’ Peanut (Arachis hypogaea) Allergen Powder-deep (Palforzia) to relieve allergic reactions, including anaphylaxis, that…